Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil

por Hard, Marjie L., Wehr, Angela Y., Sadler, Brian M., Mills, Richard J., von Moltke, Lisa
Publicado 2018

Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia

por Hard, Marjie L., Wehr, Angela Y., Du, Yangchun, Weiden, Peter J., Walling, David, von Moltke, Lisa
Publicado 2018

Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model

por Hard, Marjie L., Mills, Richard J., Sadler, Brian M., Wehr, Angela Y., Weiden, Peter J., von Moltke, Lisa
Publicado 2017

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

por McConnell, Scott A, Desai, Dharmik N, Faldu, Sejal P, Hard, Marjie L, Wehr, Angela Y, Weiden, Peter J, von Moltke, Lisa
Publicado 2017